福莫特醇在水管灰色中动态改变内分泌卡纳比诺伊德基调,诱导头痛
Ingrid L Peterson1, Erika Liktor-Busa1, Kelly L Karlage1
1Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, United States.
The journal of headache and pain
|November 20, 2024
概括
用于喘的formoterol可能会通过破坏内分泌系统引起头痛. 用特定的抑制剂向这个系统可以逆转这些像头痛的症状在小鼠.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 疼痛研究 疼痛研究
背景情况:
- 药物过度使用头痛 (MOH) 是一个日益严重的全球健康问题,特别是在女性中,经常伴随着光敏感性和认知问题.
- 美国食品和药物管理局 (FDA) 批准的治疗严重喘和COPD的药物Formoterol正在研究其他神经系统疾病.
- 内分泌大麻素 (eCB) 系统在头痛病理生理学中发挥作用,缺陷与这种疾病有关.
研究的目的:
- 在临床前的模型中调查formoterol在诱导头痛类行为方面的潜力.
- 在疼痛的背景下,探索formoterol和内分泌系统之间的相互作用.
- 为了确定是否针对eCB系统可以减轻formoterol诱导的头痛症状.
主要方法:
- 雌性小鼠每天服用甲醇,长达42天.
- 行为评估包括围绕轨道体,开放场测试,新型物体识别和光敏感性.
- 使用LC-MS.量化了周水道灰色 (PAG) 中的内分类素水平和大麻素受体1 (CB1R) 表达.
主要成果:
- 在小鼠中,formoterol诱导了周围轨道的全体运动和光敏感性.
- 治疗改变了内分泌大麻素安纳米德 (AEA) 和2-阿拉基多诺伊尔糖醇 (2-AG) 的水平,以及CB1R表达.
- eCB系统的抑制剂和一种大麻素受体激动剂逆转了formoterol诱导的全力学.
结论:
- 福尔摩特不调节内分泌氨酸基调,导致类似头痛的围绕轨道.
- 这些发现表明,对于接受formoterol的患者来说,可能存在预防策略.
- 这项研究强调了eCB系统与疼痛中的上腺体信号之间的复杂关系.
相关概念视频
Analgesia and Pain Management
513
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
513
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
202
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
202
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
163
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
163
Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
Antiasthma Drugs: Methylxanthines
195
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
195
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.2K


